Flucytosine
"Flucytosine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fluorinated cytosine analog that is used as an antifungal agent.
Descriptor ID |
D005437
|
MeSH Number(s) |
D03.383.742.698.421.431
|
Concept/Terms |
Ancobon- Ancobon
- Alcobon
- CSP Brand of Flucytosine
- Roche Brand of Flucytosine
- Allphar Brand of Flucytosine
- Dermatech Brand of Flucytosine
- ICN Pharmaceuticals Brand of Flucytosine
- Ancotil
|
Below are MeSH descriptors whose meaning is more general than "Flucytosine".
Below are MeSH descriptors whose meaning is more specific than "Flucytosine".
This graph shows the total number of publications written about "Flucytosine" by people in this website by year, and whether "Flucytosine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1988 | 0 | 1 | 1 | 1996 | 1 | 0 | 1 | 1997 | 1 | 0 | 1 | 2000 | 0 | 1 | 1 | 2003 | 0 | 2 | 2 | 2005 | 0 | 1 | 1 | 2013 | 1 | 0 | 1 | 2014 | 1 | 0 | 1 | 2016 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Flucytosine" by people in Profiles.
-
Zhu TH, Rodriguez PG, Behan JW, Declerck B, Kim GH. Cryptococcal cellulitis on the shin of an immunosuppressed patient. Dermatol Online J. 2016 Jun 15; 22(6).
-
Perumalla SR, Paul S, Sun CC. Enabling the Tablet Product Development of 5-Fluorocytosine by Conjugate Acid Base Cocrystals. J Pharm Sci. 2016 06; 105(6):1960-1966.
-
Perumalla SR, Sun CC. Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering. J Pharm Sci. 2014 Apr; 103(4):1126-32.
-
Perumalla SR, Pedireddi VR, Sun CC. Design, synthesis, and characterization of new 5-fluorocytosine salts. Mol Pharm. 2013 Jun 03; 10(6):2462-6.
-
Conrad C, Miller CR, Ji Y, Gomez-Manzano C, Bharara S, McMurray JS, Lang FF, Wong F, Sawaya R, Yung WK, Fueyo J. Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther. 2005 Mar; 12(3):284-94.
-
Vricella LA, Khambadkone S, Yates R, Tsang VT. Right ventricular inflow obstruction from massive fungal vegetation presenting as neonatal circulatory collapse. Eur J Cardiothorac Surg. 2003 Aug; 24(2):323-4.
-
Vilchez R, Shapiro R, McCurry K, Kormos R, Abu-Elmagd K, Fung J, Kusne S. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int. 2003 May; 16(5):336-40.
-
Fortunato JE, Mauceri HJ, Kocharyan H, Song RH, Salloum R, Vosicky J, Swedberg K, Malik S, Abusharif F, Glagov S, Weichselbaum RR, Bassiouny HS. Gene therapy enhances the antiproliferative effect of radiation in intimal hyperplasia. J Surg Res. 2000 Apr; 89(2):155-62.
-
Hanna NN, Mauceri HJ, Wayne JD, Hallahan DE, Kufe DW, Weichselbaum RR. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Cancer Res. 1997 Oct 01; 57(19):4205-9.
-
Dong Y, Wen P, Manome Y, Parr M, Hirshowitz A, Chen L, Hirschowitz EA, Crystal R, Weichselbaum R, Kufe DW, Fine HA. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther. 1996 Apr 10; 7(6):713-20.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|